Inactive Instrument

Sector Chart Celldex Therapeutics, Inc. Nasdaq

Equities

US15117B1035

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
4.66TCr -
4.17TCr
4.12TCr
3.24TCr -
2.82TCr